Xenobiotic metabolism: A view through the metabolometer

Chemical Research in Toxicology

Volumn 23, Issue 5, 2010, Pages 851-860

  Patterson, Andrew D ^a   Gonzalez, Frank J ^a   Idle, Jeffrey R ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 5 AMINO 6,8 DIFLUORO 2 (3 FLUOROPHENYL) 7 METHYL 4H 1 BENZOPYRAN 4 ONE; AMINOFLAVONE; ARECAIDINE; ARECOLINE; ARECOLINE 1 OXIDE; FLAVONE DERIVATIVE; MELATONIN; UNCLASSIFIED DRUG;

CHEMOMETRICS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; NONHUMAN; REVIEW; TRANSGENIC MOUSE; XENOBIOTIC METABOLISM;

ANIMALS; ARECOLINE; FLAVONOIDS; HUMANS; IMIDAZOLES; MELATONIN; METABOLOMICS; MICE; MUTAGENS; XENOBIOTICS;

ANIMALIA; ARECA; MUS; MUS MUSCULUS;

EID: 77952337695     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100020p     Document Type: Review

References (61)

1. Idle, J. R. and Gonzalez, F. J. (2007) Metabolomics Cell Metab. 6, 348-351
2. Martins, J. C. and Vasconcelos, V. M. (2009) Microcystin dynamics in aquatic organisms J. Toxicol. Environ. Health, Part B 12, 65-82
3. Zinedine, A., Soriano, J. M., Molto, J. C., and Manes, J. (2007) Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin Food Chem. Toxicol. 45, 1-18
4. Williams, R. T. (1959) Detoxication Mechanisms. The Metabolism and Detoxication of Drugs, Toxic Substances and Other Organic Compounds, 2 nd ed., John Wiley & Sons Inc., New York.
5. Williams, R. T. (1963) Detoxication mechanisms in man Clin. Pharmacol. Ther. 4, 234-254
6. Miller, J. A. and Miller, E. C. (1975) Metabolic activation and reactivity of chemical carcinogens Mutat. Res. 33, 25-26
7. Persky, L., Krohmer, J. S., and Storaasli, J. P. (1957) Clinical studies of excretion and localization of diethyl stilbestrol diphosphate labelled with radioactive phosphorus (P32) Surg. Forum 8, 610-613
8. Arnold, H., Bourseaux, F., and Brock, N. (1958) Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B 518-ASTA) in experimental tumours of the rat Nature 181, 931
9. Holmes, E., Nicholson, J. K., and Tranter, G. (2001) Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks Chem. Res. Toxicol. 14, 182-191
10. Nicholson, J. K., Lindon, J. C., and Holmes, E. (1999) Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29, 1181-1189
11. Kaddurah-Daouk, R., Kristal, B. S., and Weinshilboum, R. M. (2008) Metabolomics: a global biochemical approach to drug response and disease Annu. Rev. Pharmacol. Toxicol. 48, 653-683
12. Griffin, J. L. (2006) Understanding mouse models of disease through metabolomics Curr. Opin. Chem. Biol. 10, 309-315
13. Chen, C., Gonzalez, F. J., and Idle, J. R. (2007) LC-MS-based metabolomics in drug metabolism Drug Metab. Rev. 39, 581-597
14. Griffin, J. L. and Bollard, M. E. (2004) Metabonomics: its potential as a tool in toxicology for safety assessment and data integration Curr. Drug Metab. 5, 389-398
15. Wishart, D. S. (2010) Computational approaches to metabolomics Methods Mol. Biol. 593, 283-313
16. Trygg, J., Holmes, E., and Lundstedt, T. (2007) Chemometrics in metabonomics J. Proteome Res. 6, 469-479
17. Mortishire-Smith, R. J., Castro-Perez, J. M., Yu, K., Shockcor, J. P., Goshawk, J., Hartshorn, M. J., and Hill, A. (2009) Generic dealkylation: a tool for increasing the hit-rate of metabolite rationalization, and automatic customization of mass defect filters Rapid Commun. Mass Spectrom. 23, 939-948
18. Mortishire-Smith, R. J., OConnor, D., Castro-Perez, J. M., and Kirby, J. (2005) Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis Rapid Commun. Mass Spectrom. 19, 2659-2670
19. CAS (2009) The Latest CAS Registry Number and Substance Count, Chemical Abstracts Service, Columbus, OH.
20. Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H., and Loeb, L. A. (2004) Environmental and chemical carcinogenesis Semin. Cancer Biol. 14, 473-486
21. Plumb, R. S., Stumpf, C. L., Granger, J. H., Castro-Perez, J., Haselden, J. N., and Dear, G. J. (2003) Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids Rapid Commun. Mass Spectrom. 17, 2632-2638
22. Bateman, K. P., Castro-Perez, J., Wrona, M., Shockcor, J. P., Yu, K., Oballa, R., and Nicoll-Griffith, D. A. (2007) MSE with mass defect filtering for in vitro and in vivo metabolite identification Rapid Commun. Mass Spectrom. 21, 1485-1496
23. Plumb, R. S., Rainville, P. D., Potts, W. B., 3rd, Castro-Perez, J. M., Johnson, K. A., and Wilson, I. D. (2007) High-temperature ultra-performance liquid chromatography coupled to hybrid quadrupole time-of-flight mass spectrometry applied to ibuprofen metabolites in human urine Rapid Commun. Mass Spectrom. 21, 4079-4085
24. Sun, J., Von Tungeln, L. S., Hines, W., and Beger, R. D. (2009) Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis J. Chromatogr., B 877, 2557-2565
25. Liu, A., Patterson, A. D., Yang, Z., Zhang, X., Liu, W., Qiu, F., Sun, H., Krausz, K. W., Idle, J. R., Gonzalez, F. J., and Dai, R. (2009) Fenofibrate metabolism in the cynomolgus monkey using ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabolomics Drug Metab. Dispos. 37, 1157-1163
26. Felton, J. S., Knize, M. G., Wu, R. W., Colvin, M. E., Hatch, F. T., and Malfatti, M. A. (2007) Mutagenic potency of food-derived heterocyclic amines Mutat. Res. 616, 90-94
27. Cheung, C., Ma, X., Krausz, K. W., Kimura, S., Feigenbaum, L., Dalton, T. P., Nebert, D. W., Idle, J. R., and Gonzalez, F. J. (2005) Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2 Chem. Res. Toxicol. 18, 1471-1478
28. Sinha, R. (2002) An epidemiologic approach to studying heterocyclic amines Mutat. Res. 506-507, 197-204
29. Chen, C., Ma, X., Malfatti, M. A., Krausz, K. W., Kimura, S., Felton, J. S., Idle, J. R., and Gonzalez, F. J. (2007) A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach Chem. Res. Toxicol. 20, 531-542
30. Gu, D., McNaughton, L., Lemaster, D., Lake, B. G., Gooderham, N. J., Kadlubar, F. F., and Turesky, R. J. (2010) A comprehensive approach to the profiling of the cooked meat carcinogens, 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine. Chem. Res. Toxicol. [online early access], DOI: 10.1021/tx900436m, published online Mar 1, 2010.
31. Gupta, P. C. and Warnakulasuriya, S. (2002) Global epidemiology of areca nut usage Addict. Biol. 7, 77-83
32. Winstock, A. (2002) Areca nut-abuse liability, dependence and public health Addict. Biol. 7, 133-138
33. IARC (2004) Betel-Quid and Areca-Nut Chewing and Some Areca-Nut-Derived Nitrosamines, IARC, Lyon, France.
34. Giri, S., Idle, J. R., Chen, C., Zabriskie, T. M., Krausz, K. W., and Gonzalez, F. J. (2006) A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse Chem. Res. Toxicol. 19, 818-827
35. Giri, S., Krausz, K. W., Idle, J. R., and Gonzalez, F. J. (2007) The metabolomics of ()-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases Biochem. Pharmacol. 73, 561-573
36. Patterson, A. D., Lanz, C., Gonzalez, F. J., and Idle, J. R. (2009) The role of mass spectrometry-based metabolomics in medical countermeasures against radiation. Mass Spectrom. Rev. [online early access], DOI: 10.1002/mas.20272, published online Nov 4, 2009.
37. Bubenik, G. A. (2008) Thirty four years since the discovery of gastrointestinal melatonin J. Physiol. Pharmacol. 59 (Suppl. 2) 33-51
38. Ma, X., Chen, C., Krausz, K. W., Idle, J. R., and Gonzalez, F. J. (2008) A metabolomic perspective of melatonin metabolism in the mouse Endocrinology 149, 1869-1879
39. Ma, X., Idle, J. R., Krausz, K. W., Tan, D. X., Ceraulo, L., and Gonzalez, F. J. (2006) Urinary metabolites and antioxidant products of exogenous melatonin in the mouse J. Pineal Res. 40, 343-349
40. Viswanathan, A. N. and Schernhammer, E. S. (2009) Circulating melatonin and the risk of breast and endometrial cancer in women Cancer Lett. 281, 1-7
41. Cardinali, D. P., Esquifino, A. I., Srinivasan, V., and Pandi-Perumal, S. R. (2008) Melatonin and the immune system in aging Neuroimmunomodulation 15, 272-278
42. Srinivasan, V., Spence, D. W., Pandi-Perumal, S. R., Trakht, I., and Cardinali, D. P. (2008) Therapeutic actions of melatonin in cancer: possible mechanisms Integr. Cancer Ther. 7, 189-203
43. Sakano, K., Oikawa, S., Hiraku, Y., and Kawanishi, S. (2004) Oxidative DNA damage induced by a melatonin metabolite, 6-hydroxymelatonin, via a unique non-o-quinone type of redox cycle Biochem. Pharmacol. 68, 1869-1878
44. Maharaj, D. S., Maharaj, H., Antunes, E. M., Maree, D. M., Nyokong, T., Glass, B. D., and Daya, S. (2005) 6-Hydroxymelatonin protects against quinolinic-acid-induced oxidative neurotoxicity in the rat hippocampus J. Pharm. Pharmacol. 57, 877-881
45. Maharaj, D. S., Maharaj, H., Daya, S., and Glass, B. D. (2006) Melatonin and 6-hydroxymelatonin protect against iron-induced neurotoxicity J. Neurochem. 96, 78-81
46. Hirata, F., Hayaishi, O., Tokuyama, T., and Seno, S. (1974) In vitro and in vivo formation of two new metabolites of melatonin J. Biol. Chem. 249, 1311-1313
47. Akama, T., Shida, Y., Sugaya, T., Ishida, H., Gomi, K., and Kasai, M. (1996) Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer J. Med. Chem. 39, 3461-3469
48. Phillips, L. R., Bramhall, C., Buckley, J., Wolfe, T., House, T. L., and Stinson, S. F. (2000) Identification of the principal circulating metabolite of a synthetic 5,4′-diaminoflavone (NSC 686288), an antitumor agent, in the rat J. Chromatogr., B 741, 205-211
49. Kuffel, M. J., Schroeder, J. C., Pobst, L. J., Naylor, S., Reid, J. M., Kaufmann, S. H., and Ames, M. M. (2002) Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2 Mol. Pharmacol. 62, 143-153
50. Chen, C., Meng, L., Ma, X., Krausz, K. W., Pommier, Y., Idle, J. R., and Gonzalez, F. J. (2006) Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone) J. Pharmacol. Exp. Ther. 318, 1330-1342
51. Meng, L. H., Shankavaram, U., Chen, C., Agama, K., Fu, H. Q., Gonzalez, F. J., Weinstein, J., and Pommier, Y. (2006) Activation of aminoflavone (NSC 686288) by a sulfotransferase is required for the antiproliferative effect of the drug and for induction of histone gamma-H2AX Cancer Res. 66, 9656-9664
52. Meng, L. H., Meng, Z., Miao, Z. H., Veenstra, T. D., and Pommier, Y. (2008) Cytokeratin-RNA cross-linking mediated by the antitumor aminoflavone, 5-amino-2,3-fluorophenyl-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one J. Pharmacol. Exp. Ther. 325, 674--680
53. Wiegand, R., Wu, J., Sha, X., LoRusso, P., Heath, E., and Li, J. (2009) Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma J. Chromatogr., B 877, 1460-1464
54. Nicholson, J. K. and Wilson, I. D. (2003) Opinion: understanding global systems biology: metabonomics and the continuum of metabolism Nat. Rev. Drug Discovery 2, 668-676
55. Patterson, A. D., Slanar, O., Krausz, K. W., Li, F., Hofer, C. C., Perlik, F., Gonzalez, F. J., and Idle, J. R. (2009) Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation J. Proteome Res. 8, 4293-4300
56. Frolkis, A., Knox, C., Lim, E., Jewison, T., Law, V., Hau, D. D., Liu, P., Gautam, B., Ly, S., Guo, A. C., Xia, J., Liang, Y., Shrivastava, S., and Wishart, D. S. (2010) SMPDB: The Small Molecule Pathway Database Nucleic Acids Res. 38, D480-D487
57. Lim, E., Pon, A., Djoumbou, Y., Knox, C., Shrivastava, S., Guo, A. C., Neveu, V., and Wishart, D. S. (2010) T3DB: a comprehensively annotated database of common toxins and their targets Nucleic Acids Res. 38, D781-D786
58. Forsythe, I. J. and Wishart, D. S. (2009) Exploring human metabolites using the human metabolome database Curr. Protoc. Bioinf. Chapter14 (Unit14) 18
59. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B., Hau, D. D., Psychogios, N., Dong, E., Bouatra, S., Mandal, R., Sinelnikov, I., Xia, J., Jia, L., Cruz, J. A., Lim, E., Sobsey, C. A., Shrivastava, S., Huang, P., Liu, P., Fang, L., Peng, J., Fradette, R., Cheng, D., Tzur, D., Clements, M., Lewis, A., De Souza, A., Zuniga, A., Dawe, M., Xiong, Y., Clive, D., Greiner, R., Nazyrova, A., Shaykhutdinov, R., Li, L., Vogel, H. J., and Forsythe, I. (2009) HMDB: a knowledgebase for the human metabolome Nucleic Acids Res. 37, D603-D610
60. Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., Fung, C., Nikolai, L., Lewis, M., Coutouly, M. A., Forsythe, I., Tang, P., Shrivastava, S., Jeroncic, K., Stothard, P., Amegbey, G., Block, D., Hau, D. D., Wagner, J., Miniaci, J., Clements, M., Gebremedhin, M., Guo, N., Zhang, Y., Duggan, G. E., Macinnis, G. D., Weljie, A. M., Dowlatabadi, R., Bamforth, F., Clive, D., Greiner, R., Li, L., Marrie, T., Sykes, B. D., Vogel, H. J., and Querengesser, L. (2007) HMDB: the Human Metabolome Database Nucleic Acids Res. 35, D521-D526
61. Lawton, K. A., Berger, A., Mitchell, M., Milgram, K. E., Evans, A. M., Guo, L., Hanson, R. W., Kalhan, S. C., Ryals, J. A., and Milburn, M. V. (2008) Analysis of the adult human plasma metabolome Pharmacogenomics 9, 383-397